欧盟HMA药品数据库（European Union HMA Authorisation of Medicines DataBase）
MR编号
FR/H/0419/006
药品名称
PERIOLIMEL N4E
活性成分
Glucose 0.0 00
剂型
Emulsion for infusion
上市许可持有人
BAXTER SAS 6 avenue Louis Pasteur 78310 Maurepas
参考成员国 - 产品名称
France (FR)
互认成员国 - 产品名称
Luxembourg (LU)
Spain (ES)
Cyprus (CY)
OLIMEL PERI N4E EMULSION FOR INFUSION
Latvia (LV)
Malta (MT)
Norway (NO)
Poland (PL)
Olimel N9
Romania (RO)
OLIMEL N9E
Sweden (SE)
Hungary (HU)
OLIMEL 9 g/l nitrogén emulziós infúzió
Finland (FI)
Estonia (EE)
Czechia (CZ)
PERIOLIMEL N4E
Bulgaria (BG)
Greece (GR)
OLIMEL
Italy (IT)
Austria (AT)
PeriOLIMEL 2,5 % mit Elektrolyten - Emulsion zur Infusion
Ireland (IE)
United Kingdom (Northern Ireland) (XI)
Iceland (IS)
Netherlands (NL)
Belgium (BE)
Denmark (DK)
Germany (DE)
Olimel Peri 2,5% E Emulsion zur Infusion
Slovenia (SI)
Portugal (PT)
Lithuania (LT)
OLIMEL PERI N4E infuzinė emulsija
Slovakia (SK)
OLIMEL PERI N4E
许可日期
2009/10/23
最近更新日期
2025/05/05
药物ATC编码
B05BA10 combinations
申请类型
TypeLevel1：
Known Active Substance
TypeLevel2：
Initial Application
TypeLevel3：
Full Dossier Art 8.3(i) Dir 2001/83/EC
TypeLevel4：
Chemical Substance
TypeLevel5：
Non Prescription (including OTC)
附件文件下载
Final Product Information
|
common_pl_cleanconsolidatedR1 with RMS additional recommended changes
Date of last change:2024/09/06
Final Product Information
|
common_spc_cleanconsolidatedR1 with RMS additional recommended changes
Date of last change:2024/09/06
Final PL
|
FR_H_0419_01_06_IA_040_d30_approval_20161019
Date of last change:2024/09/06
市场状态
Positive
©2006-2025
Drugfuture
->
European Union HMA Authorisation of Medicines DataBase